Loading...
Tevogen Bio Holdings Inc.
TVGN•NASDAQ
HealthcareBiotechnology
$1.43
$0.02(1.42%)
Tevogen Bio Holdings Inc. (TVGN) Company Profile & Overview
Explore Tevogen Bio Holdings Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Tevogen Bio Holdings Inc. (TVGN) Company Profile & Overview
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
SectorHealthcare
IndustryBiotechnology
CEODr. Ryan H. Saadi M.D., M.P.H, M.P.H.
Contact Information
Company Facts
18 Employees
IPO DateJan 5, 2022
CountryUS
Actively Trading